Total Payments
$4,271
2024 Payments
$109.64
Companies
32
Transactions
286
Medicare Patients
4,831
Medicare Billing
$418,525
Payment Breakdown by Category
Food & Beverage$4,179 (97.8%)
Education$92.30 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,179 | 276 | 97.8% |
| Education | $92.30 | 10 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $574.66 | 18 | $0 (2023) |
| Lilly USA, LLC | $410.76 | 27 | $0 (2022) |
| GlaxoSmithKline, LLC. | $340.42 | 54 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $304.08 | 18 | $0 (2021) |
| Allergan, Inc. | $275.59 | 19 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $274.92 | 15 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $249.64 | 11 | $0 (2024) |
| PFIZER INC. | $212.72 | 19 | $0 (2019) |
| Astellas Pharma US Inc | $180.18 | 5 | $0 (2023) |
| Novo Nordisk Inc | $167.18 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.64 | 1 | Otsuka America Pharmaceutical, Inc. ($109.64) |
| 2023 | $317.29 | 5 | E.R. Squibb & Sons, L.L.C. ($131.32) |
| 2022 | $152.07 | 3 | E.R. Squibb & Sons, L.L.C. ($121.42) |
| 2021 | $34.47 | 2 | E.R. Squibb & Sons, L.L.C. ($20.40) |
| 2020 | $221.78 | 13 | Kowa Pharmaceuticals America, Inc. ($49.81) |
| 2019 | $2,041 | 128 | Lilly USA, LLC ($285.42) |
| 2018 | $766.71 | 74 | GlaxoSmithKline, LLC. ($152.39) |
| 2017 | $628.45 | 60 | GlaxoSmithKline, LLC. ($147.08) |
All Payment Transactions
286 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $109.64 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $108.89 | General |
| Category: Biological | ||||||
| 10/05/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $60.85 | General |
| Category: Endocrinology | ||||||
| 06/07/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $108.45 | General |
| Category: Cardiovascular | ||||||
| 04/10/2023 | E.R. Squibb & Sons, L.L.C. | ABILIFY (Drug) | Education | In-kind items and services | $22.87 | General |
| Category: Neuroscience | ||||||
| 03/02/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.23 | General |
| Category: PSYCHOLOGY | ||||||
| 11/10/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $121.42 | General |
| Category: Cardiovascular | ||||||
| 07/20/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Neuroscience | ||||||
| 06/02/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 08/04/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $20.40 | General |
| Category: Cardiovascular | ||||||
| 06/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/29/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/03/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2020 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Endocrinology | ||||||
| 03/05/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $27.72 | General |
| Category: Cardiovascular | ||||||
| 03/04/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO ELLIPTA | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: NEUROSCIENCE | ||||||
| 02/18/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Central Nervous System | ||||||
| 02/06/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $29.21 | General |
| Category: Cardiovascular | ||||||
| 01/30/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: VACCINES | ||||||
| 01/17/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $22.09 | General |
| Category: Cardiovascular | ||||||
| 01/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: DIABETES | ||||||
| 01/03/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.45 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,101 | 1,479 | $283,801 | $100,605 |
| 2022 | 18 | 1,121 | 1,404 | $273,493 | $95,707 |
| 2021 | 17 | 1,266 | 1,647 | $320,221 | $118,812 |
| 2020 | 20 | 1,343 | 1,721 | $313,231 | $103,401 |
Total Patients
4,831
Total Services
6,251
Medicare Billing
$418,525
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 304 | 559 | $177,412 | $40,328 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 244 | 244 | $33,370 | $29,719 | 89.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 86 | 91 | $11,921 | $6,508 | 54.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $12,075 | $6,487 | 53.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 60 | $13,155 | $3,368 | 25.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 22 | $11,748 | $3,264 | 27.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 92 | 97 | $6,638 | $2,806 | 42.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $2,960 | $2,647 | 89.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 216 | 315 | $2,874 | $2,623 | 91.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 25 | $9,900 | $2,102 | 21.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $1,748 | $752.18 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 306 | 556 | $171,640 | $40,516 | 23.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 246 | 246 | $32,365 | $30,638 | 94.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 21 | 21 | $11,025 | $5,839 | 53.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 74 | 75 | $9,773 | $5,131 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 71 | $15,061 | $3,414 | 22.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 79 | 81 | $5,346 | $2,266 | 42.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 26 | $10,136 | $2,217 | 21.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 16 | 16 | $4,063 | $2,121 | 52.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 37 | 37 | $2,442 | $1,041 | 42.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 11 | 11 | $3,608 | $515.85 | 14.3% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2022 | 11 | 12 | $1,680 | $466.79 | 27.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 38 | 38 | $1,634 | $397.33 | 24.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 116 | 127 | $1,143 | $371.21 | 32.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 15 | 16 | $1,104 | $266.42 | 24.1% |
About Dr. Daniel Lemkuil, MD
Dr. Daniel Lemkuil, MD is a Family Medicine healthcare provider based in Green Bay, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730163437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Lemkuil, MD has received a total of $4,271 in payments from pharmaceutical and medical device companies, with $109.64 received in 2024. These payments were reported across 286 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,179).
As a Medicare-enrolled provider, Lemkuil has provided services to 4,831 Medicare beneficiaries, totaling 6,251 services with total Medicare billing of $418,525. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Green Bay, WI
- Active Since 12/06/2005
- Last Updated 12/29/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1730163437
Products in Payments
- ELIQUIS (Drug) $582.65
- XARELTO (Drug) $261.54
- REXULTI (Drug) $249.64
- JARDIANCE (Drug) $219.00
- VRAYLAR (Drug) $208.15
- Ozempic (Drug) $150.63
- ADVAIR (Drug) $111.25
- Veozah (Drug) $108.89
- TRULICITY (Drug) $108.89
- Strensiq (Drug) $106.52
- Trintellix (Drug) $105.12
- ENTRESTO (Drug) $93.72
- CHANTIX (Drug) $88.69
- BEVESPI AEROSPHERE (Drug) $86.36
- EUCRISA (Drug) $85.37
- TRELEGY ELLIPTA (Drug) $72.50
- XIFAXAN (Drug) $71.32
- MYRBETRIQ (Drug) $71.29
- Aimovig (Biological) $66.43
- Hetlioz (Drug) $62.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Green Bay
Mark Jenson, M.d, M.D
Family Medicine — Payments: $211,802
Family Medicine $211,802
Stephen Hathway, Md, MD
Family Medicine — Payments: $110,565
Family Medicine $110,565
Dr. Lisa Allen, M.d, M.D
Family Medicine — Payments: $23,625
Family Medicine $23,625
Matthew Jenson, Md, MD
Family Medicine — Payments: $10,257
Family Medicine $10,257
Dr. Marjorie Delo, Md, MD
Family Medicine — Payments: $4,355
Family Medicine $4,355
Melissa Hidde, Md, MD
Family Medicine — Payments: $3,625
Family Medicine $3,625